Results 111 to 120 of about 1,618 (156)

Genotype in the diagnosis of 21-hydroxylase deficiency: who should undergo CYP21A2 analysis?

open access: yes, 2013
AMS: to confirm the diagnosis of 21-hydroxylase deficiency (21-OHD) by the analysis of CYP21A2 gene in infants with clinical and/or biochemical features of 21-OHD in order to clarify which patients to submit to genetic analysis; to analyze the genotype ...
GAUDINO, Rossella   +7 more
core   +1 more source

Functional analysis of two rare CYP21A2 mutations detected in Italian patients with a mildest form of congenital adrenal hyperplasia

open access: yes, 2009
P>Background More than 90% of all cases of congenital adrenal hyperplasia (CAH) result from steroid 21-hydroxylase gene (CYP21A2) mutations. Most of these mutations result from intergenic recombinations between CYP21A2 and closely linked CYP21A1P ...
Giardina, Bruno   +25 more
core   +1 more source

Spectrum of CYP21A2 Variants: A Retrospective Single-center Study from a Tertiary Healthcare Center in Türkiye

open access: yesGazi Medical Journal
Objective: Congenital adrenal hyperplasia due to 21-hydroxylase deficiency is a common autosomal recessive disorder caused by pathogenic variants in the CYP21A2 gene.
Ahmet Kablan   +5 more
doaj   +1 more source

Junction Site Analysis of Chimeric CYP21A1P/CYP21A2 Genes in 21-Hydroxylase Deficiency

open access: yes, 2012
BACKGROUND Chimeric CYP21A1P/CYP21A2 genes, caused by homologous recombination between CYP21A2 (cytochrome P450, family 21, subfamily A, polypeptide 2) and its highly homologous pseudogene CYP21A1P (cytochrome P450, family 21, subfamily
Gabriela P Finkielstain   +6 more
core   +1 more source

Challenging Molecular Diagnosis of Congenital Adrenal Hyperplasia (CAH) Due to 21-Hydroxylase Deficiency: Case Series and Novel Variants of CYP21A2 Gene

open access: yesCurrent Issues in Molecular Biology
Congenital adrenal hyperplasia (CAH) is a group of autosomal recessive genetic defects in cortisol synthesis and shows elevated ACTH concentrations, which in turn has downstream effects.
Paola Concolino
doaj   +1 more source

Differential Inhibition of CYP17A1 and CYP21A2 Activities by the P450 Oxidoreductase Mutant A287P.

open access: yes, 2007
P450 oxidoreductase (POR) has a pivotal role in facilitating electron transfer from nicotinamide adenine dinucleotide phosphate to microsomal cytochrome P450 (CYP) enzymes, including the steroidogenic enzymes CYP17A1 and CYP21A2.
Hannah E Ivison (16064012)   +6 more
core  

Genetic Defects of the CYP21A2 Gene in Girls With Premature Adrenarche

open access: yesJournal of Endocrinological Investigation, 2015
Objectives To seek evidence on the prevalence of CYP21A2 genetic defects and consequences in girls with premature adrenarche (PA).<p></p> Methods The study included 59 girls diagnosed with PA.
Phedonos, A.A.P.   +6 more
exaly   +4 more sources

CYP17A1 Inhibitor Abiraterone, an Anti-Prostate Cancer Drug, Also Inhibits the 21-Hydroxylase Activity of CYP21A2 [PDF]

open access: yesJournal of Steroid Biochemistry and Molecular Biology, 2017
Abiraterone is an inhibitor of CYP17A1 which is used for the treatment of castration resistant prostate cancer. Abiraterone is known to inhibit several drug metabolizing cytochrome P450 enzymes including CYP1A2, CYP2D6, CYP2C8, CYP2C9, CYP2C19, CYP3A4 ...
Amit V. Pandey   +2 more
exaly   +5 more sources

Home - About - Disclaimer - Privacy